.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
QuintilesIMS
Daiichi Sankyo
US Army
Cipla
Colorcon
US Department of Justice
Farmers Insurance
Johnson and Johnson

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021212

« Back to Dashboard

NDA 021212 describes CAVERJECT IMPULSE, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from two suppliers. Additional details are available on the CAVERJECT IMPULSE profile page.

The generic ingredient in CAVERJECT IMPULSE is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.

Summary for 021212

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)

Pharmacology for NDA: 021212

Medical Subject Heading (MeSH) Categories for 021212

Suppliers and Packaging for NDA: 021212

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212 NDA Pharmacia and Upjohn Company LLC 0009-5181 0009-5181-01 2 SYRINGE in 1 CARTON (0009-5181-01) > .5 mL in 1 SYRINGE (0009-5181-10)
CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212 NDA Pharmacia and Upjohn Company LLC 0009-5182 0009-5182-01 2 SYRINGE in 1 CARTON (0009-5182-01) > .5 mL in 1 SYRINGE (0009-5182-11)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.01MG/VIAL
Approval Date:Jun 11, 2002TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.02MG/VIAL
Approval Date:Jun 11, 2002TE:RLD:No

Expired Orange Book Patents for NDA: 021212

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And UpjohnCAVERJECT IMPULSEalprostadilINJECTABLE;INJECTION021212-001Jun 11, 2002► Subscribe► Subscribe
Pharmacia And UpjohnCAVERJECT IMPULSEalprostadilINJECTABLE;INJECTION021212-002Jun 11, 2002► Subscribe► Subscribe
Pharmacia And UpjohnCAVERJECT IMPULSEalprostadilINJECTABLE;INJECTION021212-002Jun 11, 2002► Subscribe► Subscribe
Pharmacia And UpjohnCAVERJECT IMPULSEalprostadilINJECTABLE;INJECTION021212-002Jun 11, 2002► Subscribe► Subscribe
Pharmacia And UpjohnCAVERJECT IMPULSEalprostadilINJECTABLE;INJECTION021212-001Jun 11, 2002► Subscribe► Subscribe
Pharmacia And UpjohnCAVERJECT IMPULSEalprostadilINJECTABLE;INJECTION021212-001Jun 11, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Citi
Harvard Business School
Deloitte
Farmers Insurance
McKesson
Fuji
Federal Trade Commission
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot